Mirvetuximab
Modify Date: 2024-01-16 14:18:15
Mirvetuximab structure
|
Common Name | Mirvetuximab | ||
|---|---|---|---|---|
| CAS Number | 1453084-36-0 | Molecular Weight | N/A | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | N/A | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of MirvetuximabMirvetuximab (M9346A) is an anti-FOLR1 (folate receptor 1) monoclonal antibody. Mirvetuximab is the antibody moiety of novel folate receptor alpha (FRα)-targeting ADC (Mirvetuximab soravtansine). Mirvetuximab soravtansine can be used in ovarian and other FRα-positive cancer research[1]. |
| Name | Mirvetuximab |
|---|
| Description | Mirvetuximab (M9346A) is an anti-FOLR1 (folate receptor 1) monoclonal antibody. Mirvetuximab is the antibody moiety of novel folate receptor alpha (FRα)-targeting ADC (Mirvetuximab soravtansine). Mirvetuximab soravtansine can be used in ovarian and other FRα-positive cancer research[1]. |
|---|---|
| Related Catalog | |
| References |
| No Any Chemical & Physical Properties |